Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002757210 | SCV003574538 | uncertain significance | Inborn genetic diseases | 2021-08-12 | criteria provided, single submitter | clinical testing | The c.6068A>T (p.D2023V) alteration is located in exon 38 (coding exon 38) of the DYNC2H1 gene. This alteration results from a A to T substitution at nucleotide position 6068, causing the aspartic acid (D) at amino acid position 2023 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |